Because the side effect profile of SGLT2is differs from that of GLP-1RAs, any additive negative interaction is not expected when these two classes of anti-diabetic medications are used in combination [11]
Predictors for the risk and severity of post-thrombotic syndrome in vascular Behets disease
The most common complaints were nausea (55% versus 12.6% with placebo), constipation (30.7% versus 11.6%), and vomiting (26.1% versus 4.1%)
Patients should also tell surgical and anesthesia teams about GLP-1 or tirzepatide treatment before procedures involving general anesthesia or deep sedation because current labeling includes warnings related to delayed gastric emptying and pulmonary aspiration
But I think that you, if you're gonna see someone new, they need to do a full history, a family history, a personal history, and really understand your risk and be able to answer all of your questions and be there for you when you do have side effects